Whittier Trust Co. Boosts Holdings in SPDR S&P Biotech ETF $XBI

Whittier Trust Co. lifted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 8.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 257,702 shares of the exchange traded fund’s stock after acquiring an additional 19,767 shares during the period. Whittier Trust Co. owned 0.40% of SPDR S&P Biotech ETF worth $33,192,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Avoro Capital Advisors LLC acquired a new position in SPDR S&P Biotech ETF during the fourth quarter worth approximately $256,053,000. Wells Fargo & Company MN boosted its holdings in shares of SPDR S&P Biotech ETF by 75.7% in the 4th quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock valued at $434,835,000 after purchasing an additional 1,536,122 shares during the last quarter. OMERS ADMINISTRATION Corp grew its stake in shares of SPDR S&P Biotech ETF by 42,425.2% during the 4th quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock valued at $145,147,000 after buying an additional 1,187,907 shares during the period. Morgan Stanley grew its stake in shares of SPDR S&P Biotech ETF by 8.3% during the 4th quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock valued at $1,401,181,000 after buying an additional 882,718 shares during the period. Finally, Assetmark Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 1,042,265.6% during the 4th quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock worth $77,528,000 after buying an additional 635,782 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI opened at $160.46 on Monday. The firm has a market capitalization of $10.85 billion, a P/E ratio of 11.47 and a beta of 0.82. The stock’s fifty day simple moving average is $137.41 and its 200 day simple moving average is $130.02. SPDR S&P Biotech ETF has a twelve month low of $83.02 and a twelve month high of $160.82.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.